USPTO serial 79430371
BEAMS
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- TMO LAW OFFICE 121
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BEAMS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development services in the field of medical therapies, namely, basic, clinical and preclinical medical research, developing innovative therapeutic solutions in the nature of pharmaceutical preparations and medicines, and performing scientific feasibility studies aimed at diagnosing, preventing and treating pathologies in all medical fields; pharmacological, biological, microbiological, genetic, biotechnological and biomedical research services; designing and developing medical and scientific research, namely, conducting clinical and preclinical trials for others; scientific research in analyzing and interpreting biomedical data and health data; scientific laboratory analysis and therapeutic test services with a view to developing new treatments; advice on product research and development for precision and customized therapies; implementing of computer technologies for others for therapeutic simulation, molecular modeling and research in artificial intelligence applied to life sciences; consultation with respect to medical research; scientific research; technical scientific and medical research; software design in the therapeutic field; software development in the field of medical devices; research and development of new products for third parties; quality control for others; laboratory tests, namely, laboratory testing of materials; studying and conducting medical research projects, namely, conducting of feasibility studies in the field of new pharmaceutical technologies; engineering; provision and exchange of knowledge, industrial know-how and data information and consultation in the field of scientific research and development; providing technical expertise consultation and advice in the field of scientific research for medical purposes; piloting working groups bringing together scientists and industrial experts to solve health problems in the nature of consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following an accidental or terrorist caused release of chemical, biological, radiological or nuclear materials; design, development, scientific and medical research and engineering services in the field of medical devices; consultation with respect to the design and development of medical devices; scientific research, analysis and technical engineering assessment services of medical device design and development; services for the testing, and certification being testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards and quality control of medical devices; providing temporary use of online non-downloadable computer aided design (CAD) software for designing medical devices. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 15, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 15, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 15, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 25, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 8, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 8, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 29, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 28, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |